July 19 (Reuters) - EPAT Technologies Ltd EPT.AX
* EPAT pain assessment app secures regulatory clearance-ept.ax
* Australian commercialisation of EPAT app remains on schedule for Q4 2017 and europe during 2018
* Epat app is now cleared for use as a medical device in Australia (TGA) and CE marked for European markets